Patent Yard Sign in
Expired Canadian patentCanada

Medicaments containing 5-alkyl-pyrimidine nucleosides and use as cytostatic and virostatic agents

CA 1162853 A · Owner: Robugen G.M.B.H. Pharmazeutische Fabrik · Inventors: Gauri, Kailash K.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

5-Alkyl-pyrimidine nucleosides of the formula: ( I ), in which R represents alkyl having 2 to 10 carbon atoms x represents hydrogen, or hydroxy and y represents a variety of functional carbonyl-containing groups are disclosed for use in medicaments for the treatment of malignant diseases in immunosuppressive therapy, and as cytostatic and virostatic agents. They may also be used for potentiating the action of 5-fluorouracil. Also disclosed are medicaments containing a 5-alkyl-pyrimidine nucleoside of formula I either alone or in combination with 5-fluorouracil in a pharmaceutically, acceptable carrier.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 28, 1984. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 28, 2001.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 18, 1981
GrantedFebruary 28, 1984
Term endedFebruary 28, 2001
Patent numberCA 1162853 A
Classification (IPC)A61K31/70 +2 more

Timeline

Timeline From CIPO dates

1982198419861988199019921994199619982000Application filedMarch 18, 1981Patent grantedFeb 28, 1984Term endedFeb 28, 2001

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.